PATENT CLAIM ANALYSIS

Application Number: 15876401
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-06
Patent Classification: ["549", "282000"]

Abstract:
Psoralen compounds of compounds having formulae 1A-10A, 1B-10B, 1C-10C, 1D-10D, 1E-10E, 1F-10F, 1G-10G, and 1H-5H as shown in FIG.  1,  and pharmaceutically acceptable salts thereof; and their use in methods for the treatment of a cell proliferation disorder in a subject, pharmaceutical compositions containing the psoralen derivatives, a kit for performing the method, and a method for causing an autovaccine effect in a subject using the method.

Claim (Index 5):
A method for producing an autovaccine in a subject, comprising:\n (1) providing a population of target cells from the subject; (2) treating the target cells ex vivo with a psoralen compound selected from the group consisting of compounds having the following formulas: and\n a pharmaceutically acceptable salt thereof; \n (3) activating the psoralen compound with a UV-A source to induce apoptosis in the target cells; and \n (4) returning the apoptic cells back to the subject to induce an autovaccine effect against the target cells, wherein the apoptic cells cause an autovaccine effect.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 86.0
- Lexical Diversity: 1.62
- Patent Class: 549.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11935655', '14603539', '14573511', '15786046', '13054279']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.711665899190182
- 35 USC 102 Novelty (BERT): 0.5389116479420346
- Combined Prediction Score: 0.6943904740653672
- Mean Citation Score: 360.017622
- Max Citation Score: 367.34283
- Similarity Product: 254.58704579203248

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test